RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90) and c) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ

This recall is currently active, issued December 11, 2024. It was issued by Rising Pharma Holding, Inc..

Company
Rising Pharma Holding, Inc.
Recall Initiated
November 19, 2024
Posted
December 11, 2024
Recall Number
D-0106-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
122,925 bottles
Firm Location
East Brunswick, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit

Distribution

Nationwide.

Lot / Code Info

a) 30s; DT3023019A, exp. date Jan-25 DT3023050A, exp. date Apr-25; b) 90s; DT3023022A, exp. date Jan-25; c) 1000s; DT3022108A, DT3022107A, DT3022106A, DT3022111A, DT3022109A, exp. date Nov-24, DT3023001A, DT3023003A, exp. date Dec-24, DT3023024A, DT3023020B, exp. date Jan-25 DT3023027A, DT3023028A, exp. date Feb-25, DT3023034A, exp. date Mar-25, DT3023049A, exp. date Apr-25, DT3023095A, exp. date Jul-25

More recalls by Rising Pharma Holding, Inc.

View all recalls by this company →

Other recent Class II Drug recalls